vs
BRC Inc.（BRCC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是BRC Inc.的1.8倍（$197.9M vs $112.7M），REPLIGEN CORP净利率更高（6.7% vs -2.8%，领先9.6%），REPLIGEN CORP同比增速更快（13.6% vs 6.5%），REPLIGEN CORP自由现金流更多（$17.6M vs $-9.4M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.0%）
BRC Inc.是一家美国高端咖啡与生活方式品牌，主营烘焙咖啡豆、即饮咖啡饮品、品牌服饰及户外装备，核心客群包含退伍军人、急救人员与户外爱好者，在北美地区通过电商及线下实体门店渠道销售产品。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BRCC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$112.7M
营收增速更快
RGEN
高出7.2%
6.5%
净利率更高
RGEN
高出9.6%
-2.8%
自由现金流更多
RGEN
多$27.0M
$-9.4M
两年增速更快
RGEN
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.7M | $197.9M |
| 净利润 | $-3.2M | $13.3M |
| 毛利率 | 32.1% | 52.5% |
| 营业利润率 | -6.3% | 9.0% |
| 净利率 | -2.8% | 6.7% |
| 营收同比 | 6.5% | 13.6% |
| 净利润同比 | -29.3% | 143.9% |
| 每股收益（稀释后） | $-0.02 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRCCRGEN
| Q4 25 | $112.7M | $197.9M | ||
| Q3 25 | $100.7M | $188.8M | ||
| Q2 25 | $94.8M | $182.4M | ||
| Q1 25 | $90.0M | $169.2M | ||
| Q4 24 | $105.9M | $174.1M | ||
| Q3 24 | $98.2M | $154.9M | ||
| Q2 24 | $89.0M | $154.1M | ||
| Q1 24 | $98.4M | $151.3M |
净利润BRCCRGEN
| Q4 25 | $-3.2M | $13.3M | ||
| Q3 25 | $-486.0K | $14.9M | ||
| Q2 25 | $-5.3M | $14.9M | ||
| Q1 25 | $-2.9M | $5.8M | ||
| Q4 24 | $-2.5M | $-30.3M | ||
| Q3 24 | $-535.0K | $-654.0K | ||
| Q2 24 | $-482.0K | $3.3M | ||
| Q1 24 | $548.0K | $2.1M |
毛利率BRCCRGEN
| Q4 25 | 32.1% | 52.5% | ||
| Q3 25 | 36.9% | 53.2% | ||
| Q2 25 | 33.9% | 50.0% | ||
| Q1 25 | 36.1% | 53.6% | ||
| Q4 24 | 38.1% | 26.1% | ||
| Q3 24 | 42.1% | 50.0% | ||
| Q2 24 | 41.9% | 49.8% | ||
| Q1 24 | 42.9% | 49.5% |
营业利润率BRCCRGEN
| Q4 25 | -6.3% | 9.0% | ||
| Q3 25 | 0.5% | 8.9% | ||
| Q2 25 | -13.3% | 7.6% | ||
| Q1 25 | -6.0% | 3.9% | ||
| Q4 24 | -2.1% | -17.7% | ||
| Q3 24 | 1.1% | -5.1% | ||
| Q2 24 | 1.1% | 1.0% | ||
| Q1 24 | 4.0% | 1.3% |
净利率BRCCRGEN
| Q4 25 | -2.8% | 6.7% | ||
| Q3 25 | -0.5% | 7.9% | ||
| Q2 25 | -5.6% | 8.2% | ||
| Q1 25 | -3.2% | 3.4% | ||
| Q4 24 | -2.3% | -17.4% | ||
| Q3 24 | -0.5% | -0.4% | ||
| Q2 24 | -0.5% | 2.2% | ||
| Q1 24 | 0.6% | 1.4% |
每股收益（稀释后）BRCCRGEN
| Q4 25 | $-0.02 | $0.24 | ||
| Q3 25 | $0.00 | $0.26 | ||
| Q2 25 | $-0.07 | $0.26 | ||
| Q1 25 | $-0.04 | $0.10 | ||
| Q4 24 | $-0.03 | $-0.55 | ||
| Q3 24 | $-0.01 | $-0.01 | ||
| Q2 24 | $-0.01 | $0.06 | ||
| Q1 24 | $0.01 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $767.6M |
| 总债务越低越好 | $34.7M | $542.2M |
| 股东权益账面价值 | $45.7M | $2.1B |
| 总资产 | $209.2M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.76× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BRCCRGEN
| Q4 25 | $4.3M | $767.6M | ||
| Q3 25 | $9.5M | $748.7M | ||
| Q2 25 | $4.3M | $708.9M | ||
| Q1 25 | $3.9M | $697.2M | ||
| Q4 24 | $6.8M | $757.4M | ||
| Q3 24 | $7.3M | $784.0M | ||
| Q2 24 | $9.6M | $809.1M | ||
| Q1 24 | $4.0M | $780.6M |
总债务BRCCRGEN
| Q4 25 | $34.7M | $542.2M | ||
| Q3 25 | $35.0M | $537.9M | ||
| Q2 25 | $72.7M | — | ||
| Q1 25 | $68.8M | — | ||
| Q4 24 | $65.1M | $525.6M | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $66.5M | — | ||
| Q1 24 | $61.5M | — |
股东权益BRCCRGEN
| Q4 25 | $45.7M | $2.1B | ||
| Q3 25 | $48.0M | $2.1B | ||
| Q2 25 | $10.1M | $2.1B | ||
| Q1 25 | $11.2M | $2.0B | ||
| Q4 24 | $13.2M | $2.0B | ||
| Q3 24 | $14.5M | $2.0B | ||
| Q2 24 | $14.9M | $2.0B | ||
| Q1 24 | $14.6M | $2.0B |
总资产BRCCRGEN
| Q4 25 | $209.2M | $2.9B | ||
| Q3 25 | $222.4M | $2.9B | ||
| Q2 25 | $225.3M | $2.9B | ||
| Q1 25 | $222.9M | $2.9B | ||
| Q4 24 | $227.4M | $2.8B | ||
| Q3 24 | $233.7M | $2.8B | ||
| Q2 24 | $229.9M | $2.9B | ||
| Q1 24 | $227.2M | $2.8B |
负债/权益比BRCCRGEN
| Q4 25 | 0.76× | 0.26× | ||
| Q3 25 | 0.73× | 0.26× | ||
| Q2 25 | 7.19× | — | ||
| Q1 25 | 6.15× | — | ||
| Q4 24 | 4.94× | 0.27× | ||
| Q3 24 | 4.47× | — | ||
| Q2 24 | 4.46× | — | ||
| Q1 24 | 4.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-9.4M | $17.6M |
| 自由现金流率自由现金流/营收 | -8.3% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-13.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BRCCRGEN
| Q4 25 | $-8.7M | $25.7M | ||
| Q3 25 | $6.4M | $48.1M | ||
| Q2 25 | $-3.3M | $28.6M | ||
| Q1 25 | $-4.1M | $15.0M | ||
| Q4 24 | $2.2M | $39.2M | ||
| Q3 24 | $1.9M | $49.3M | ||
| Q2 24 | $2.3M | $42.2M | ||
| Q1 24 | $4.9M | $44.7M |
自由现金流BRCCRGEN
| Q4 25 | $-9.4M | $17.6M | ||
| Q3 25 | $5.6M | $43.4M | ||
| Q2 25 | $-4.3M | $21.5M | ||
| Q1 25 | $-5.3M | $11.4M | ||
| Q4 24 | $504.0K | $33.6M | ||
| Q3 24 | $-205.0K | $42.3M | ||
| Q2 24 | $147.0K | $37.4M | ||
| Q1 24 | $2.2M | $36.4M |
自由现金流率BRCCRGEN
| Q4 25 | -8.3% | 8.9% | ||
| Q3 25 | 5.5% | 23.0% | ||
| Q2 25 | -4.5% | 11.8% | ||
| Q1 25 | -5.9% | 6.8% | ||
| Q4 24 | 0.5% | 19.3% | ||
| Q3 24 | -0.2% | 27.3% | ||
| Q2 24 | 0.2% | 24.3% | ||
| Q1 24 | 2.2% | 24.0% |
资本支出强度BRCCRGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 0.8% | 2.5% | ||
| Q2 25 | 1.0% | 3.9% | ||
| Q1 25 | 1.3% | 2.1% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 2.2% | 4.5% | ||
| Q2 24 | 2.4% | 3.1% | ||
| Q1 24 | 2.8% | 5.5% |
现金转化率BRCCRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 8.97× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRCC
| Sales Channel Through Intermediary | $72.9M | 65% |
| Sales Channel Directly To Consumer | $34.4M | 31% |
| Outpost | $5.4M | 5% |
RGEN
暂无分部数据
